Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.43 |
| ▸ | NPY1R | P25929 | 7/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18760234 | 0.90 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL16690663 | 0.90 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL18760211 | 0.90 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL16690636 | 0.90 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL18760235 | 0.90 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL23873721 | 0.84 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RSIRT5 | |
| Cystine SCHEMBL12475493 | 0.83 | DDAH1 (0.48) | NOS2DDAH1 | |
| Cystine SCHEMBL12475490 | 0.83 | DDAH1 (0.48) | NOS2DDAH1 | |
| Etelcalcetide SCHEMBL20869502 | 0.82 | SIRT5 (0.44) | NPY4RNPY1RNPY2RNPY5RSIRT5 | |
| Etelcalcetide SCHEMBL20869503 | 0.82 | SIRT5 (0.44) | NPY4RNPY1RNPY2RNPY5RSIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038671-A1 | Efficient Synthesis of CN2097 and RC7 and Their Analogs | RHODE ISLAND BOARD OF EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038671-A1 | Efficient Synthesis of CN2097 and RC7 and Their Analogs | MRPS27, CNOT7, PRMT7 | NPY4R 386/4885NPY1R 360/4885NPY2R 393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.